tiprankstipranks
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Holding SPRY?
Track your performance easily

ARS Pharmaceuticals (SPRY) Technical Analysis

344 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
3Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
ARS Pharmaceuticals’s (SPRY) Moving Averages Convergence Divergence (MACD) indicator is -0.21, suggesting ARS Pharmaceuticals is a Sell.
ARS Pharmaceuticals’s (SPRY) 20-Day exponential moving average is 11.73, while ARS Pharmaceuticals’s (SPRY) share price is $12.57, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 50-Day exponential moving average is 12.46, while ARS Pharmaceuticals’s (SPRY) share price is $12.57, making it a Buy.

ARS Pharmaceuticals (SPRY) Pivot Points

Jan 19, 2025, 12:16 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.31
10.76
11.47
11.92
12.63
13.08
13.79
Fibonacci
10.76
11.20
11.48
11.92
12.36
12.64
13.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ARS Pharmaceuticals (SPRY) Moving Averages

Jan 19, 2025, 12:16 AM
Period
Simple
Exponential
MA5
11.88Buy
12.02Buy
MA10
11.57Buy
11.72Buy
MA20
11.28Buy
11.73Buy
MA50
12.96Sell
12.46Buy
MA100
13.53Sell
12.62Sell
MA200
11.62Buy
11.30Buy
ARS Pharmaceuticals’s (SPRY) 10-Day exponential moving average is 11.72, while ARS Pharmaceuticals’s (SPRY) share price is $12.57, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 100-Day exponential moving average is 12.62, while ARS Pharmaceuticals’s (SPRY) share price is $12.57, making it a Sell.
ARS Pharmaceuticals’s (SPRY) stock price is $12.57 and ARS Pharmaceuticals’s (SPRY) 50-day simple moving average is 12.96, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) stock price is $12.57 and ARS Pharmaceuticals’s (SPRY) 100-day simple moving average is 13.53, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) stock price is $12.57 and ARS Pharmaceuticals’s (SPRY) 200-day simple moving average is 11.62, creating a Buy signal.

ARS Pharmaceuticals (SPRY) Technical Indicators

Jan 19, 2025, 12:16 AM
Name
Value
Implied Action
RSI (14)
58.87
Neutral
STOCH (9,6)
81.26
Sell
STOCHRSI (14)
83.73
Sell
MACD (12,26)
-0.21
Sell
ADX (14)
25.37
Neutral
Williams %R
-15.02
Sell
CCI (14)
275.51
Sell
ATR (14)
0.85
-
Ultimate Oscillator
55.96
Neutral
ROC
12.74
Buy
ARS Pharmaceuticals’s (SPRY) Relative Strength Index (RSI) is 58.87, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Trend Strength Indicator (ADX) is 25.37, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Commodity Channel Index (CCI) is 275.51, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) Price Rate of Change (ROC) is 12.74, creating a Buy signal.

FAQ

Is SPRY a Buy, Hold, or Sell?
Based on SPRY’s technical indicators, SPRY is a Buy.
    What is SPRY’s RSI (14)?
    SPRY’s RSI (14) is 58.87, which suggests SPRY is a Neutral.
      What is SPRY’s MACD?
      SPRY’s MACD is -0.21, which suggests SPRY is a Sell.
        What is SPRY’s 5-day moving average?
        SPRY’s 5-day moving average is 11.88, which suggests SPRY is a Buy.
          What is SPRY’s 20-day moving average?
          SPRY 20-day moving average is 11.28, which suggests SPRY is a Buy.
            What is SPRY’s 50-day moving average?
            SPRY’s 50-day moving average is 12.96, which suggests SPRY is a Sell.
              What is SPRY’s 200-day moving average?
              SPRY’s 200-day moving average is 11.62, which suggests SPRY is a Buy.
                What is SPRY’s Williams % R (14)?
                SPRY’s Williams % R (14) is -15.02, which suggests SPRY is a Sell.
                  What is SPRY’s CCI (14)?
                  SPRY’s CCI (14) is 275.51, which suggests SPRY is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis